In synthesis, it may be postulated that the increased levels of soluble ICOS and ICOS-L may reflect a local overexpression in the lungs of ICOS non-Tregs and ICOS-L on endothelial cells, which may have a pathogenetic role in the development of PAH. The gene discussed is ICOSLG; the disease is pulmonary arterial hypertension.